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ABSTRACT 
The potentiometric studies have been carried out on divalent metal 
ions with sulfamethazine, Pyridoxal 5-phosphate and DL-cystine. The 
Calvin-Bjerrum pH-metric titration technique, as modified by Irving and 
Rossotti, has been applied to determine the stepwise protonation constants 
and stepwise formation constants of the metal complexes in aqueous 
medium. The ionic strength was maintained constant at 0,1 M by adding 
NaCl(lM) solution. 
The results indicate that one proton of sulfamethazine and two protons 
each of pyridoxal 5-phosphate and DL-Cystine were being released in the 
pH range 4.0 to 10.0. 
Stability of sulfamethazine, Pyridoxal-5-phosphate and DL-Cystine 
upon complexation with divalent metal ions deceases with an increase in pH 
following Irving William series: 
Mn(II) < Fe(II) < Co(II) < Ni(II) < Cu(II) 
The thermodynamic parameters that is, Gibbs free energy (AG), 
Entropy (AS) and Enthalpy (AH) have also evaluated from the stability 
constant. 
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INTRODUCTION 
The sulfa drugs are synthetic antimicrobial agents with a wide 
spectrum encompassing most gram positive and gram negative 
organisms. These drugs are employed systematically for the 
prevention and cure of bacterial infections. 
The first sulfa drug, prontosil was discovered by the German 
physician and chemist, Gerhard Domagk in 1935. He observed that 
prontosil protects mice against streptococcal infections. The 
sulfonamide is a generic name for derivatives of para-
aminobenzenesulfonamide (sulfanilamide). In the liver it exists as 
follows: 
H2N- /y -N=N-HfJ ) -S02-NH2 ^ ^ ^ > H^N-Z^V-NH^ 2i 
Prontosil NH2 
+ 
H 2 N - / V-SO2NH2 
Sulfanilamide 
Sulfa drugs are white crystalline powder and sparingly 
soluble in water. They readily react with alkali and form salts 
which are more soluble than the parent drug. 
They kill bacteria and fungi by interfering with their 
metabolism. They were the "wonder drugs" before penicillin was 
discovered. They are used mainly for the treatment of urinary tract 
infections (UTI). 
Sulfa drugs are usually not allergic by themselves but when a 
sulfonamide molecule is metabolized in the body, it becomes 
capable of attaching to proteins. The allergy is, therefore, not 
related to the original drug but a drug-protein complex. The 
antibacterial activity of sulfonamides is related to its pKa value. 
Maximum activity is found in those having pKa value between 
6.0-7.5. Various types of complexes of sulfa drugs Schiff bases of 
rare-earth metal ions were synthesized and characterized by 
potentiometric studies earlier [1,2]. 
Due to the presence of amino group, sulfa drugs form schiff 
bases with various types of aldehyde and keto compounds. The 
voltammetric and potentiometric studies of some sulfa drug-Schiff-
base compounds and their metal complexes have been described 
earlier [3]. Spectral and thermal studies of ternary complexes of 
nickel with sulfasalazine and some amino acids were studied in 
which sulfasalazine is used as primary ligand and amino acids as 
secondary ligand [4]. 
N=^ 
*^M-H >-S02-NH-< ) 
The metal complexes of Schiff-base derived from sulfadiazine 
and an amine display obvious inhibitor effects against gram 
positive and gram negative bacteria. Transition metal complexes of 
Schiff base derived from sulfadiazine and salicylaldehyde have 
been extensity studied by UV-Vis, conductance, polarography, ESR 
and TGA. They have also exhibited antibacterial and anti-fungal 
properties in solution [5], 
\ / 
NHR' 
^ B u ^ O ^ \ = / 
NHR^  
The organotin (IV) form complexes with biologically active 
sulfa drug Schiff base. They have also been found to be highly 
active against bacteria and fungi [6]. Sulfamethazine has been used 
to treat bacterial diseases in human and veterinary medicine and to 
promote growth in cattle, sheep, pigs and poultry. It produces 
thyroid-tumours in mice and rats by a non-genotoxic mechanism, 
which involves inhibition of thyroid peroxidase resulting in 
alterations in thyroid , 
(sulfamethazine) 
Sulfamethazine is widely used in veterinary medicine in 
combination with chlorotetracycline and penicillin in pigs for 
maintenance of weight gain in the presence of atrophic rhinitis, 
growth promotion and increased feed efficiency. The potentiometric 
and thermodynamic studies of 2-acrylamidosulfamethazine and its 
metal complexes in mono and polymeric forms have been 
characterized by elemental analysis and IR studies in 40% (v/v) 
ethanol water mixture [7]. 
Synthesis and equilibrium studies of metal complexes of 
sulfamethazine have been investigated by potentiometric techniques 
in acidic solution and also characterized by elemental analysis, 
electrolytic conductance, IR, 'H NMR, mass spectra and 
thermogravimetric studies [8]. 
It is water soluble and colourless in aqueous solution. Due to 
the presence of free amino group, it forms Schiff-base with 
aldehyde and keto compounds easily. 
, , . . . „._// \ S O 2 — N H — ^ 
(Schiff base of sulfamethazine and PLP) 
Pyridoxal-5-phosphate is metabolically active form of 
vitamin B6. It works as a coenzyme in a large group of specific 
enzyme catalyzed reactions of amino-group transfer, 
decarboxylation and other metabolic transformations of individual 
amino acids [9]. 
(Pyridoxal 5-phosphate) 
Vitamin B6 is first Okidlzed to pyridoxal and rapidly 
phosphorylated to pyridoxal 5-phosphate in liver. It is the main 
circulating form of vitamin B6. It is a brown powder and dissolves 
in water to give a pale yellow colour. Only this form can be used by 
enzyme involved in the biological process of nitrogen, protein and 
haeme synthesis [10]. 
Pyridoxal 5-phosphate is used as coenzyme in many 
biological reactions. Coenzymes are low molecular weight 
substances that provide unique chemical functionalities for certain 
enzyme complexes. 
All water soluble vitamins, except vitamin-C are coenzymes 
or precursor of coenzymes. They can act as carriers of specific 
functional groups i.e. methyl, acetyl groups. . The second order rate 
constant for complex formation between PLP and cysteine has been 
determined as function of pH [11]. Pyridoxal 5-phosphate participates 
in a wide variety of reactions involving amino acids, as: 
1. Transamination reaction. 
2. a and p decarboxylation. 
3. p and y elimination. 
4. Racemization. 
5. Aldol reactions 
These reactions occur due to the ability of pyridoxal 5-phosphate 
to form stable Schiff base with amino group of a amino acids [12]. 
The rate constant of hydrolysis and formation of Schiff bases 
formed by pyridoxal 5-phosphate with L-tryptophan and their 
methyl and n-butyl esters at variable pH and IS^C and at O.IM 
ionic strength has been reported [13]. Pyridoxal 5-phosphate has 
two absorption maxima, one at 415 nm in acidic medium and the 
other at 340 nm in basic medium. PLP has been found to undergo a 
rapid benzoin type condensation in oxygen free solution when 
exposed to light [14, 15]. 
The screening of PLP dependent activities toward amino 
acids were studied which confirms that the Schiff base is an 
obligatory intermediate in all PLP dependent reactions of amino 
acids [16]. The role of PLP in the structural stabilization has been 
studied by fluorescence and ^^ P NMR [17]. 
Equilibria and absorpation spectra of various Schiff bases of 
PLP have been studied and the kinetic and thermodynamic 
parameters have been evaluated in aqueous solution as a function of 
pH and constant ionic strength [18-20]. 
Since cystine partially dissolves in water, 1-2 drops of acid 
were added to make it water soluble.lt contains two amino groups 
and two carboxyKc acid groups with a disulphide bond. It is also 
found in the zwitter-ionic form in solution. As a component, cystine 
is a significant determinant of the tertiary structure of most 
proteins. 
COOH ^COOH 
CH-CH2-S-S-CH2-CI^ 
NH2^ NH2 
(Cystine) 
The excess of cystine in the body can cause cystinosis, a rare disease 
that can cause cystine crystals to form in the body and produce bladder or 
kidney stones. This side effect has not been associated with cysteine. 
Cysteine is more easily absorbed by the body than cystine, and hence 
most supplements contain cysteine rather than cystine. 
However, cysteine is unstable, and is often converted to 
cystine in the body. To avoid the conversion of cysteine to 
potentially harmful amounts of cystine, intake of vitamin C 
supplements is advised. It is particularly abundant in skeletal and 
connective tissues, hair and digestive enzymes. Due to the presence 
of sulphur, metal complexes of DL-cystine have an important role 
in therapeutic action against toxic heavy metals. 
Cysteine is oxidized to cystine at neutral pH. In acidic 
medium, reaction does not take place while cystine is a non 
essential amino acid and synthesized by the body itself [21]. 
However, food such as eggs, meat, dairy products, and whole grains 
are also good sources of cystine. It functions as a powerful anti-
oxidant in detoxifying harmful toxins, protects the body from 
radiation damage, liver and brain damage due to alcohol, drugs, and 
toxic compounds. It has been also used in the treatment of 
rheumatoid arthritis and hardening of the arteries, promotes the 
recovery from severe burns and surgery, promotes the burning of 
fat and the building of muscle and slows down the aging process. 
Cysteine is used as a secondary ligand in the complex reactions 
with transition metal ions reported earlier [22]. People suffering from 
diabetes should be careful while taking supplementation, as it could 
inactivate insulin. 
H HC=S 
I 
H2N—CH— COOH 
L-cystine is used as precursor of p-lactum ring of penicillin. 
For biosynthesis of penicillin, cystine related compounds are 
necessary. Various methods of synthesis of a and p-methyl DL-
cystine from DL-allothreonine are described [24]. 
Many a-substituted cystines are synthesized by using a-
haloketone condensed with sodium salt of a-toluenethiol followed 
by treatment with KCN and ammonium carbonate in aqueous 
ethanol (50%) solution at 60-70 T , hydrolyzed then reduced [25]. 
Adsorption and desorption behaviour of cystine and cysteine 
in neutral and basic media were studied with gold(III) in which 
absorption of cystine takes place at different potentials. It confirms 
that cysteine monolayer presents a higher packing density than 
cystine [26]. 
The polarographic study of cystine in O.IN HCl with thymol 
as suppresser has been done. The system was not reversible and 
potentiometric titration curves were obtained for a-substituted 
cystines [27]. Incorporation of sulphur from DL-cystine to 
glutathione and protein in rat has indicated that cystine-sulphur was 
incorporated much more rapidly in glutathione than in proteins[28]. 
Metabolic studies of DL-cystine in rat showed that cystine was 
converted into pyruvate first, then it gives alanine, aspartic acid and 
glutamic acid [29]. 
10 
In this project, the stability constant and thermodynamic 
parameters of sulfamethazine, pyridoxal 5-phosphate and DL-cystine 
were determined by Calvin-Bjerrum pH-metric titration technique, as 
modified by Irving and Rossotti at O.IM ionic strength at room 
temperature. The strength of complexation between organic ligand and 
metal ions is usually expressed in terms of stability constant (LogK). 
The composition of the complex formed during the 
interaction of transition metal ions with PLP, sulfamethazine and 
DL-cystine were established by measuring the magnitude of proton 
displacement during the titration of these molecules in absence and 
presence of metal ions. 
Metal ligand stoichiometry of all the ligands was also 
determined by conductivity measurements. 
11 
EXPERIMENTAL 
Apparatus and Reagents: 
All chemicals were obtained from BDH or Loba Chemie. 
Hydrated metal chlorides (BDH), sulfamethazine(sigma), pyridoxal 
5-phosphate(Koch-Light) and DL-cystine were used as received. A 
digital pH meter (Elico LI-120) fitted with combined glass 
electrode was used. 
Titration procedure: 
The following solutions were prepared in double distilled water. 
1. O.INHCIO4 
2. 1 M NaCl 
3. 0.005 M Ligand 
4. 0.005 M Metal Chloride 
5. 0.2 M NaOH 
Strength of stock solution of perchloric acid was determined 
by titrating against standard NaOH solution. Calvin-Bjerrum 
titration technique, as modified by Irving and Rossotti was 
followed [30-32]. The following solutions were titrated separately 
against standard NaOH (0.2 M). 1 Molar NaCl solution was added 
to maintain the constant ionic strength (|i = 0.1). The total volume 
12 
in each case was made up to 50 mL by adding appropriate volume 
of CO2 free double distilled water. The metal contents were 
estimated by standard methods using EDTA titration [33]. 
Solution A: 5 mL, 0.1 N HCIO4 + 4.5 mL, 1 M NaCl + 40.5 water 
Solution B: 5 mL, 0.1 N HCIO4 + 4.5 mL, 1 M NaCl + 20 mL, 0.005 
M Ligand + 20.5 water 
Solution C: 5 mL, 0.1 N HCIO4 + 4.5 mL, 1 M NaCl + 20 mL, 0.005 
M Ligand + 5 mL, 0.005 M MCI2 + 15.5 water. 
The titration curve of solution A, B and C with alkali is called 
acid titration, ligand titration and metal-ligand titration curves, 
respectively. A plot between volume of alkali added and the 
corresponding pH values was made for each set. The complex formation 
results in the lowering of buffer region due to proton displacement. 
Calculation of n^  (Proton Ligand Formation Number): 
The acid, ligand and metal-ligand titration curves were obtained by 
plotting pH values of solutions A, B and C against volume of NaOH 
added, respectively. The ligand curve deviates from pure acid curve at 
pH-2.5, which suggests that deprotonation starts from this pH. The value 
of proton ligand formation number has been evaluated by the pointwise 
calculation method using the following equation: 
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^, ( V " - V ) ( N ° + E ° ) 
( V ° + V ' ) T ° 
where Y is the average number of dissociable protons present in the 
ligand. V and V" are the volume of NaOH consumed during acid 
and ligand titration respectively. V° is the total volume of the 
mixture. N° is the concentration of NaOH. E° is the concentration 
of acid. T°L is the initial concentration of Ligand. 
The proton ligand formation curves were obtained by plotting 
proton ligand formation number (HA) against pH. The approximate 
value of the proton ligand stability constants, LogK"and LogK" were 
evaluated by pointwise calculation using the following equations: 
LogK," = p H + L o g , „ - % - (n, <1) 
LogK," = pH+ Log,„ ^ ^ (1< n, < 2) 
Calculation of n (Metal ligand formation number): 
Metal ligand formation number is the average number of 
ligands attached per metal ion and was evaluated by using 
following equation: 
_ ^ ( V " - V " ) ( N ° + E < ' ) 
( V + V j i l . T " 
where T°M is the initial concentration of metal ion. V" and V" are 
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the volumes of NaOH consumed during ligand and complex 
titration respectively. The values of n were determined at various 
pH by pointwise calculation method. 
Calculation of pL (Free ligand exponent): 
The free ligand exponent was evaluated at various n values 
using the following equation: 
pL = Log 10 
i = 0 
>" 
anti log pH^ rv°+v" 
Where |3"n is the overall proton ligand stability constant. The 
pL values were also calculated at different pH by pointwise 
calculation method. 
Calculation of Log K (Stability Constant); 
The formation curves of the metal ligand complexes were 
obtained by plotting ii versus pL and stability constant can be 
directly estimated from them by half-integral method [34,35]. The 
stability constant was also evaluated by using following equations: 
n LogK, = pL + Log— -
1-n 
LogKj =pL + Log—— 
2 - n 
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RESULTS AND DISCUSSION 
A. pH metric titration of Sulfamethazine, 
In the case of sulfamethazine, proton ligand formation 
number (w A) shows that the molecule contains only one replaceable 
hydrogen atom. 
H2 
\ / 
S O 2 — N H — ^ 
Sulfamethazine 
The proton ligand formation number ( « A ) was obtained by 
potentiometric titration curves of acid and ligand at different pH 
(Fig. 1-5) by using pointwise-calculation method. Since « A is less 
than one (Table-1) there is only one replaceable hydrogen atom and 
therefore only LogK" is obtained. 
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Fjg.1 Potentiometric Titration Curves of Sulfamethazine 
with IVIn(ll) 
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Fig.2 Potentiometric Titration Curves of Sulfamethazine 
with Fe(ll) 
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Fig.4 Potentiometrjc Titration Curves of Sulfamethazine 
with Ni(il) 
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Fig.5 PotentJometric Titration Curves of Suifamethazine 
wi thCu( l l ) 
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Table-1 
Proton Ligand Formation Number («A)Of Sulfamethazine 
(SMZ) at different pH. 
pH 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
6.5 
7.0 
7.5 
8.0 
8.5 
9.0 
9.5 
10.0 
n A(sulfamethazine) 
0.94 
0.80 
0.72 
0.66 
0.58 
0.56 
0.54 
0.52 
0.48 
0.42 
0.38 
0.32 
0.29 
0.21 
The protonation constants (Table 2) of sulfamethazine LogK," and 
LogK," were directly obtained by plotting n^ versus pH value. The pH at 
fi, =1.5and iT^  =0.5 refers to LogK," and LogK^ * respectively. This is 
known as Bjerrum^s half- integral method. 
22 
Table-2 
Protonation constants of sulfamethazine 
Half-integral method 
Pointwise calculation method 
LogK" 
7.00 
7.02 
LogPi: 
7.00 
7.02 
Proton ligand formation curve (Fig, 6) were obtained by plotting 
n^ versus pH of the system. The protonation constant can be directly 
obtained by using Bjerrum's half-integral method [38, 39]. 
1.0-, 
0.9 
I 0.8-
E 
0.7-
0.6-
•O 0.5-1 
c 
3> 
= 0.4 H 
c 
o 
1 0.3-
Q. 
0.2. 
- | ' 1 ' 1 
9 10 11 
Fig.6 Proton ligand fonnation curve of Sulfomethazine at u = 0.1 M 
23 
The metal ligand formation number (n) was calculated by 
potentiometric titration curves of ligand and complex from the n ^ 
value and protonation constant (^^8*^2) by pointwise calculation 
method at different pH values. 
Since metal ligand formation number (ii) is less than one,it is 
presumed that the complex is formed in 1:1 (M:L) ratio, except in 
the case of Co(II) and Ni(II) complexes where sulfamethazine to 
metal ratio is 1:2 [40]. The complex forming tendency increases 
on moving from manganese through copper which is indicated by 
metal-ligand formation number (n). 
The free ligand concentration (pL) of sulfamethazine was 
obtained by the pointwise-calculation method at different pH 
values with the help of ii value and, protonation constant (LogK^^ 
The values of proton ligand formation number (n) and free ligand 
concentration (pL) are given intable-3. 
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Table-3 
Metal Ligand Formation Number and Free Ligand-
Concentration (pL) of Sulfamethazine. 
pH 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
6.5 
7.0 
7.5 
8.0 
8.5 
9.0 
9.5 
10.0 
Mn 
n 
0.16 
0.18 
0.20 
0.26 
0.30 
0.37 
0.42 
0.49 
0.52 
0.58 
0.62 
0.64 
0.66 
0.69 
pL 
8.68 
8.19 
7.72 
7.21 
6.25 
6.06 
5.19 
4.32 
3.81 
3.50 
3.10 
2.88 
2.62 
2.40 
Fe 
n 
0.17 
0.19 
0.21 
0.30 
0.33 
0.37 
0.44 
0.5 
0.55 
0.6 
0.64 
0.67 
0.70 
0.72 
pL 
8.81 
8.35 
7.86 
7.39 
6.88 
6.35 
5.60 
5.12 
4.60 
4.21 
3.80 
3.36 
2.80 
2.43 
Co 
n 
0.18 
0.22 
0.29 
0.35 
0.46 
0.61 
0.71 
0.89 
1.05 
1.32 
1.40 
1.56 
1.70 
1.88 
pL 
8.84 
8.42 
7.90 
7.50 
6.92 
6.45 
5.60 
5.13 
4.56 
4.20 
3.82 
3.41 
2.90 
2.56 
Ni 
n 
0.21 
0.30 
0.34 
0.41 
0.56 
0.78 
0.88 
1.02 
1.24 
1.47 
1.61 
1.72 
1.83 
1.95 
pL 
8.92 
8.51 
7.95 
7.56 
6.96 
6.48 
5.66 
5.19 
4.39 
3.98 
3.53 
3.05 
2.70 
2.31 
Cu 
n 
0.39 
0.46 
0.52 
0.59 
0.61 
0.66 
0.70 
0.75 
0.79 
0.82 
0.85 
0.89 
0.92 
0.96 
pL 
9.12 
8.61 
8.11 
7.68 
7.19 
6.71 
6.30 
5.71 
5.28 
4.75 
4.29 
3.76 
3.25 
2.71 
Since metal ligand formation number (n) increases with 
increasing pH, it suggests that complex formation is favourable in 
basic medium. 
The metal-ligand formation curves (Fig.7) were obtained by 
plotting n versus pL values [41,42]. The stability constants of the 
sulfamethazine-complexes can also be directly obtained by half-
25 
integral method (Table 4) in which n=0.5 for Log Ki and n=1.5 for 
Log Ki 
2 . 0 -
1 .8 -
1 .6 -
I J 
I 10-
i 0.8 
0 . 6 -
0.4 -
0 . 2 -
0.0 
• . ^ > 
-•-Mn(l l ) 
• Fe(ll) 
A Co(ll) 
• Ni(ll) 
• Cu(ll) 
—I 
10 2 3 4 5 6 7 8 9 
Free ligand concentration (pL) 
Fig.7 Formation Curves of Sulfamethazine witfi different metal ions at ^ = 0.1 M 
Table 4 
Stability constant of sulfamethazine with divalent metal ions 
Metal ions 
Mn 
Fe 
Co 
Ni 
Cu 
Stability constant (Log K) 
Pointwise 
calculation method 
4.01 
4.07 
4.14 
4.20 
4.28 
Half integral 
Method 
4.90 
5.38 
5.80 
7.30 
7.52 
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The stability constants (Log Ki and Log K2) were also 
calaulated by pointwise calculation method (Table 5) at different pH 
values. The stability constant decreases gradually with increasing pH. 
Table 5 
Stability constants of sulfamethazine (Log K) by pointwise 
calculation 
pH 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
6.5 
7.0 
7.5 
8.0 
8.5 
9.0 
9.5 
10 
Mn 
6.61 
6.12 
5.76 
5.40 
4.96 
4.58 
4.12 
3.80 
3.39 
3.02 
2.68 
2.31 
1.92 
1.61 
Fe 
6.72 
6.25 
5.84 
5.46 
5.01 
4.64 
4.20 
3.85 
3.45 
3.10 
2.71 
2.36 
1.94 
1.65 
Co 
6.81 
6.30 
5.90 
5.51 
5.05 
4.69 
4.36 
3.92 
3.52 
3.15 
2.78 
2.40 
1.97 
1.68 
Ni 
6.92 
6.41 
5.95 
5.62 
5.12 
4.73 
4.41 
3.96 
3.62 
3.18 
2.84 
2.42 
2.02 
1.75 
Cu 
6.98 
6.51 
6.04 
5.68 
5.18 
4.82 
4.48 
4.04 
3.76 
3.25 
2.91 
2.52 
2.06 
1.79 
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The stability constant increases gradually from Mn through 
Copper. It follows the Irving -Wil l iam's order [43]. 
Mn < Fe < Co < Ni < Cu 
A plot of LogK of the sulfamethazine-complexes vs e /r of 
metal ions (Table 6) showed a straight line (Fig.8) indicating that the 
metal-ligand(M-L) interaction is predominantly electrostatic in nature 
and results in the formation of ionic complexes although the 
possibility of some covalent interaction cannot be excluded [44,45]. 
Table 6 
Log K of sulfamethazine and e /r value of divalent metal ions 
Mn"^ 
Fe^^ 
Co^^ 
Ni^ ^ 
Cu^^ 
LogK 
4.01 
4.07 
4.14 
4.20 
4.28 
e ' / r 
4.12 
4.35 
4.52 
4.82 
4.60 
4.3 
4.25 
4.2-j 
^ 4.15 
o 4.1 
4.05-
4 
3.95 
4 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 
e'/r 
Fig.8 A plot of e^ /r verus Log K of Sulfamethazine 
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B. Conductometric Titration 
In the conductivity titrations, 20ml of sulfamethazine(lxlO'^M) 
was titrated against different metal chloride (IxlO^^M) solutions in 
aqueous medium. It was found that a 2:1 (M.L) complexes were formed 
with Co(Il) and Ni(Il) although 1:1(M:L) complexes are obtained with 
other metal ions. Precipitation of the complexes does not occur under the 
experimental conditions at room temperature. 
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Fig. 9 ConduGtometriG Titration Curves of 
Sulfamethazine with different metal ions 
The thermodynamic parameters (Table 7) were also calculated 
from the stability constants by using the following formulas [46]. 
AG=-2.303RT Log K 
AG=AH-TAS 
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With increasing stability constant of complexes, free energy 
(AG) decreases gradually from manganese to copper. It suggests 
that the reactions are spontaneous i.e. irreversible. As free energy is 
inversely proportional to the temperature, the stability constant 
decreases with increasing temperature of the system. 
Enthalpy changes (AH) accompanying the complexation of metal 
ions in solution is characteristic property of reaction. The enthalpy of 
reaction is negative and decreases from Mn to copper with increasing 
stability constant (Log K).It suggests that the reactions are exothermic. 
There will be an increase in the number of particles in the system 
leading to an mcrease in the entropy (AS) of the system. Since entropy is 
a measure of the extent of disordemess of the system, more positive value 
of entropy was observed in all the systems studied. 
Table-7 
Thermodynamic parameters for sulfamethazine 
Metal 
Mn 
Fe 
Co 
Ni 
Cu 
Log K 
4.01 
4.07 
4.14 
4.20 
4.28 
-AG (KCal) 
5.47 
5.55 
5.65 
5.73 
5.84 
-AH (Cal 
18.35 ^ 
18.62 
18.94 
19.22 
19.59 
AS (Cal/degree) 
18.28 
18.56 
18.88 
19.15 
19.51 
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A. pH metric titration of Pyridoxal 5-phosphate 
The "A value for pyridoxal 5-phosphate is more than one 
which suggests that there are two replaceable hydrogen atoms in 
the molecule. 
CHO 
OH, 1 Oil 
\ / ^ 
CH3 ^ cf ^OH 
(Pyridoxal 5-phosphate) 
The pyridoxal 5-phosphate gives a pale yellow-colour in aqueous 
solution. Since precipitation occurs in basic medium the experiment was 
performed below that pH. It was noted that the addition of alkali was 
accompanied by a gradual change in the colour of pyridoxal 5-phosphate 
from yellow to deep yellow with increasing pH. The colour change 
(Table 8) observed in presence of metal ions are almost similar to those 
observed in their absence,[47,48]. 
Table-8 
Colour change in PLP-metal system 
pH 
3.0-5.85 
5.85-10.0 
10.0 above 
Colour 
Pale yellow- deep 
Reddish 
Precipitation occurs 
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The proton ligand formation number (« A) was calculated by 
pointwise calculation method at different pH values using the acid 
and ligand titration curves (Fig. 10-14). In this experiment, the w ^ 
value is greater than one (Table 9) and therefore, protonation 
constants, LogK" and LogK" were obtained by pointwise 
calculation method. 
Table-9 
Proton Ligand Formation Number of Pyridoxal 5-phosphate (PL?) 
pH 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
6.5 
7.0 
7.5 
8.0 
8.5 
9.0 
9.5 
10.0 
« A Pyridoxal 5-phosphate (PLP) 
1.71 
1.58 
1.43 
1.36 
1.26 
1.15 
1.06 
0.92 
0.88 
0.80 
0.71 
0.58 
0.49 
0.41 
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The protonation constants (Table 10) of pyridoxal 5-phosphate, 
LogK" and LogK" were directly obtained by plotting n^ versus pH value 
(Fig. 15) by noting the pH at which n^ = 1.5 and n^ = 0.5 respectively. 
Table 10 
Protonation constants of Pyridoxal 5-phosphate. 
Half integral method 
Point wise calculation method 
LogKf 
4.52 
4.68 
LogK;" 
9.35 
8.96 
Logpr 
13.87 
13.64 
1.8 
1.6 
I.., 
c 
.2 12 
•s 
, . 
0.8 
I 0.6-
0.4-
- 1 1 1 1 1 1 1 1 1 . 1 1 1 1 , 1 1 
3 4 5 6 7 8 9 10 11 
pH 
Fig. 15 Proton ligand formation curve of Pyridoxal 5-phosphate 
Since metal ligand formation number (n) increases (Table 11) 
with increasing pH, the complex formation is favoured in basic 
medium. The metal-ligand formation number indicates that there is 
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a weak interaction of divalent metal ions of first transition series 
with pyridoxal 5-phosphate. 
Table-11 
Metal Ligand Formation Number and Free Ligand-
Concentration (pL) of Pyridoxal 5-phospliate 
pH 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
6.5 
7.0 
7.5 
8.0 
8.5 
9.0 
9.5 
10.0 
Mn 
n 
0.12 
0.14 
0.22 
0.27 
0.31 
0.37 
0.41 
0.46 
0.49 
0.52 
0.55 
0.58 
0.61 
0.63 
pL 
12.44 
11.92 
11.45 
10.96 
10.48 
9.96 
9.51 
8.97 
8.50 
8.03 
7.59 
7.10 
6.61 
6.18 
Fe 
n 
0.16 
0.18 
0.23 
0.29 
0.33 
0.40 
0.43 
0.48 
0.50 
0.53 
0.57 
0.60 
0.63 
0.66 
pL 
12.45 
11.95 
11.48 
10.84 
10.46 
9.98 
9.50 
8.96 
8.50 
7.98 
7.48 
7.01 
6.58 
6.10 
Co 
n 
0.17 
0.19 
0.26 
0.34 
0.36 
0.40 
0.44 
0.51 
0.59 
0.65 
0.71 
0.73 
0.77 
0.80 
pL 
12.50 
12.06 
11.62 
11.15 
10.61 
10.20 
Q.68 
9.21 
8.62 
8.24 
7.77 
7.26 
6.80 
6.38 
] 
n 
0.20 
0.24 
0.28 
0.36 
0.41 
0.43 
0.46 
0.53 
0.60 
0.68 
0.72 
0.75 
0.79 
0.83 
Ni 
pL 
12.60 
12.10 
11.75 
11.20 
10.63 
10.26 
9.72 
9.30 
8.71 
8.30 
7.80 
7.31 
6.84 
6.41 
Cu 
n 
0.28 
0.32 
0.37 
0.41 
0.44 
0.49 
0.52 
0.59 
0.62 
0.70 
0.73 
0.77 
0.80 
0.86 
pL 
12.65 
12.15 
11.78 
11.29 
10.69 
10.28 
9.75 
9.32 
8.76 
8.36 
7.88 
7.35 
6.85 
6.50 
The metal-ligand formation curves (Fig. 16) were obtained by plotting n 
versus pL values. The stability constants of the PLP-complexes can also be 
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directly obtained from half- integral method (Table 12) in which n=0.5 for 
Log Ki and n=1.5 for Log Ki. 
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Fig. 16 Metal ligand formation curves of PLP at ^ = 0.1 M 
Table 12 
Stability constant of Pyridoxal 5-phosphate with divalent metal ions 
Metal ions 
Mn 
Fe 
Co 
Ni 
Cu 
Stability cons 
Pointwise 
calculation method 
7.91 
8.03 
8.15 
8.45 
8.58 
tant (Log K) 
Half integral 
Method 
8.35 
8.50 
9.30 
9.42 
9.86 
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The stability constants (Log K ) of pyridoxal 5-phosphate were 
calaulated by the pointwise calculation method (Table 13) at 
different pH. It was observed that the stability constant decreases 
gradually with increasing pH of the system. 
Table-13 
Stability constants of pyridoxal 5-phosphate (Log K) by 
Pointwise Calculation Method 
pH 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
6.5 
7.0 
7.5 
8.0 
8.5 
9.0 
9.5 
10.0 
Mn 
10.79 
10.18 
9.87 
9.38 
8.92 
8.47 
8.21 
7.56 
7.28 
6.64 
6.41 
5.96 
5.67 
5.44 
Fe 
10.81 
10.21 
9.88 
9.40 
8.98 
8.52 
8.26 
7.60 
7.36 
6.78 
6.60 
^ 6.12 
5.76 
5.50 
Co 
10.83 
10.22 
9.90 
9.50 
9.08 
8.60 
8.55 
8.06 
7.79 
7.25 
6.67 
6.20 
6.16 
5.77 
Ni 
10.86 
10.24 
9.94 
9.68 
9.15 
8.91 
8.46 
8.17 
7.85 
7.42 
6.83 
6.50 
6.22 
5.87 
Cu 
10.99 
10.44 
10.06 
9.78 
9.26 
9.05 
8.76 
8.36 
8.00 
7.53 
6.96 
6.56 
6.30 
5.98 
The stability constant increases gradually from Mn through 
Cu according to the Irving -William^ s order . 
Mn < Fe <Co < Ni < Cu 
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A plot of logK of the PLP-complexes vs e^/r of different 
metal ions (Table 14) shows a straight line (Fig. 17) indicating that 
the metal-ligand (M:L)interaction is predominantly electrostatic in 
nature and results in the formation of ionic complexes although the 
possibility of some covalent interaction cannot be excluded [49]. 
Table 14 
Log K of Pyridoxal 5-phosphate and e /r value of divalent metal ions 
Mn"' 
Fe^ ^ 
Co^ ^ 
Ni"^ 
Cn'' 
LogK 
7.91 
8.03 
8.15 
8.45 
8.58 
eVr 
4.12 
4.35 
4.52 
4.82 
4.60 
8.6 n 
8 .4 -
i^ 
— 1 
8 . 
78-1 . U 
i 
-
1 
\ 42 
• ^ 
^^—• 
^ 
^ 4 
1 - 1 1 • - — 1 
4.4 46 48 I 
e^/r 
Fig.lTAplotofe^/rvslogKofPLP 
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The plot suggests interaction of electrostatic type between 
the metal ion and the pyridoxal 5-phosphate.A 1:1 (M:L) complex 
is formed between PLP and transition metal ions. 
It has been shown by Viswanathan and coworkers from NMR 
spectral data that Mn(II) and Co(II) complexes are simultaneously 
bound to the phosphate group and aldehyde-oxygen in the PLP-
complex system and stability constants of complexes indicate a 
definite interaction with ring[50,51]. 
C H 3 ^ r ^ 
where M = Mn (II), Co (II) 
B. Conductivity Titration of Pyridoxal 5-phosphate: 
In the conductivity measurements, 10ml of PLP(lxlO~'*M) was 
titrated (Fig, 18) against different metal chloride (lxlO'"*M) solutions 
in aqueous medium. It was found that a 1:1(M:L) complexes were 
formed with all the metal ions without any precipitation under the 
experimental conditions at room temperature. 
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Fig. 18 Conductometiic Titration curves of PLP-metai system 
As free energy (Table 15) decreases gradually from manganese 
to copper with increasing the stability constant,it suggests that the 
reactions are spontaneous. 
There is a decrease in the enthalpy of reaction from Mn to 
copper suggesting that reactions are exothermic. As entropy is the 
measure of randomness and it increases gradually from Mn to 
copper suggesting that complex formation tendency also increases 
from Mn to copper. 
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TabIe-15 
Thermodynamic Parameters of Pyridoxal 5-Phosphate. 
Mn 
Fe 
Co 
Ni 
Cu 
LogK 
7.91 
8.04 
8.15 
8.26 
8.39 
-AG 
(KCal) 
10.78 
10.88 
11.11 
11.26 
11.44 
-AH 
(Cal) 
36.20 
36.52 
37.30 
37.80 
38.39 
AS 
(Cal/degree/mole) 
36.08 
36.14 
37.17 
37.67 
38.26 
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A. pH metric titration of DL-Cystine 
The w A value for DL-cystine is greater than one (Table 16) which 
suggests that there are two replaceable hydrogen atoms in the molecule. 
COOJ 
' \ 
COOH 
/ 
CH-CH2-S-S-CH2-CH 
Mi{ NH2 
(Cystine) 
In acidic medium, the amino acids exist as HsN'^ RCOOH.The pH of 
initial solutions of amino acids is higher than the free acid because 
TabIe-16 
Proton Ligand Formation Number of DL-Cystine 
pH 
3.5 
4.0 
4.5 
5.0 
5.5 
#.0 
• ^ 1 - 1 ^ ^ . 5 
/ \ ^ . 0 
WA(Cystine) 
1.89 
1.72 
1.61 
1.57 
1.45 
1.28 
1.13 
0.95 
0.88 
0.71 
0.58 
0.42 
0.36 
^ 0.29 
A. pH metric titration of DL-Cystine 
The « A value for DL-cystine is greater than one (Table 16) which 
suggests that there are two replaceable hydrogen atoms in the molecule. 
COO^ 
^ / 
,CH-CH2-S-S-CH2-CI^ 
COOH 
NH-/ NHo 
(Cystine) 
In acidic medium, the amino acids exist as HsN^RCOOH.The pH of 
initial solutions of amino acids is higher than the free acid because 
TabIe-16 
Proton Ligand Formation Number of DL-Cystine 
pH 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
6.5 
7.0 
7.5 
8.0 
8.5 
9.0 
9.5 
10.0 
/7A(Cystine) 
1.89 
1.72 
1.61 
1.57 
1.45 
1.28 
1.13 
0.95 
0.88 
0.71 
0.58 
0.42 
0.36 
0.29 
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of the protonation of the basic -COO group and the dipolar ion has 
been converted to the acid form, HsN^RCOOH. 
The colourless complexes of DL-cystine formed in solution in 
acidic medium, and readily gives precipitate in alkaline medium.Due to 
very low concentration of metal ions used, the formation of polynuclear 
species was considered to be unimportant[52,53]. 
The proton ligand formation number ( « A ) was calculated by 
pointwise calculation method at different pH values using the acid 
and ligand titration curves (Fig. 19-23). 
The protonation constants (Table 17) of DL-cystine, LogKf 
and LogK" were directly obtained from a plot of n^ versus pH (Fig. 24) 
the value corresponds to n^ = 1.5 and n^ = 0.5 respectively. 
TabIe-17 
Protonation constants of DL-Cystine 
Half integral method 
Pointwise calculation method 
LogKj^ 
4.80 
4.86 
LogK^ 
8.78 
8.24 
LogPi: 
13.58 
13.10 
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Fig. 24 Proton Ligand Formation Curve of OL-Cystine 
The metal-ligand formation number (Table 18) indicates that 
there is a weak interaction of divalent metal ions of first transition 
series with DL-cystine. No precipitate was formed during the 
titration of metals with DL-cystine upto pH 8.0. 
The metal ligand formation number (« ) increases with 
increasing pH which suggests that complex formation is favoured in 
basic medium. The free ligand concentration (pL) decreases with 
the increasing pH. 
Table-18 
Metal Ligand Formation Number and Free Ligand 
Concentration of DL-Cystine. 
PH 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
6.5 
7.0 
7.5 
8.0 
8.5 
9.0 
9.5 
10.0 
Mn 
n 
0.09 
0.1 
0.12 
0.16 
0.2 
0.28 
0.33 
0.39 
0.42 
0.44 
0.49 
0.52 
0.55 
0.58 
pL 
12.88 
12.4 
11.9 
11.39 
10.9 
10.4 
9.91 
9.38 
8.95 
8.43 
7.96 
7.44 
6.92 
6.51 
Fe 
n 
0.062 
0.1 
0.13 
0.21 
0.32 
0.35 
0.4 
0.43 
0.47 
0.49 
0.51 
0.53 
0.58 
0.61 
pL 
12.9 
12.4 
11.92 
11.44 
10.93 
10.45 
9.96 
9.45 
8.96 
8.46 
7.98 
7.51 
6.98 
6.55 
Co 
n 
0.1 
0.12 
0.15 
0.23 
0.33 
0.37 
0.41 
0.44 
0.48 
0.52 
0.55 
0.58 
0.61 
0.64 
pL 
12.93 
12.4 
11.95 
11.43 
10.96 
10.45 
9.99 
9.5 
9.03 
8.58 
8.1 
7.52 
7.18 
6.57 
Ni 
n 
0.15 
0.16 
0.19 
0.28 
0.39 
0.41 
0.46 
0.5 
0.53 
0.58 
0.61 
0.64 
0.69 
0.72 
pL 
12.96 
12.5 
11.96 
11.46 
11.02 
10.51 
10.02 
9.42 
9.02 
8.46 
8.06 
7.5 
7.12 
6.6 
Cu 
n 
0.21 
0.25 
0.29 
0.32 
0.41 
0.45 
0.49 
0.52 
0.55 
0.6 
0.65 
0.69 
0.72 
0.78 
pL 
12.98 
12.52 
12.08 
11.55 
11.05 
10.55 
10.1 
9.58 
9.11 
8.61 
8.26 
7.78 
7.41 
6.92 
From a plot (Fig. 25) of « and pL, the formation curves of 
metal-complexes were obtained from which the stability constants 
(Table 19) can be obtained by half-integral method. 
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Fig. 25 Metal ligand formation curves of DL-cystine 
Table 19 
Stability constant of DL-Cystine with divalent metal ions 
Metal ions 
Mn 
Fe 
Co 
Ni 
Cu 
Stability constant (Log K) 
Pointwise 
calculation method 
8.75 
8.88 
9.24 
9.34 
9.43 
Half integral 
Method 
7.80 
8.22 
8.82 
9.53 
9.95 
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As the pH value increases, the stability constant decreases 
(Table 20) gradually. The stability constants were also calculated 
by pointwise calculation method at different pH. 
Table-20 
Stability Constants of DL-Cystine (Log K) by Pointwise 
Calculation Method 
pH 
3.5 
4.0 
4.5 
5.0 
5.5 
6.0 
6.5 
7.0 
7.5 
8.0 
8.5 
9.0 
9.5 
10.0 
Mn 
11.65 
11.17 
10.79 
10.27 
9.90 
9.40 
8.95 
8.41 
8.06 
7.71 
7.24 
6.71 
6.19 
6.06 
Fe 
11.76 
11.36 
10.88 
10.45 
9.96 
9.56 
8.98 
8.58 
8.12 
7.84 
7.44 
6.84 
6.32 
6.16 
Co 
11.96 
11.53 
11.14 
10.71 
10.33 
9.82 
3.49 
9.00 
8.60 
8.13 
7.73 
7.32 
7.06 
6.44 
Ni 
12.03 
11.65 
11.26 
10.84 
10.47 
10.02 
9.60 
9.18 
8.76 
8.30 
7.80 
7.36 
7.08 
6.48 
Cu 
12.26 
12.50 
11.62 
11.11 
10.62 
10.14 
9.65 
9.25 
8.84 
8.35 
7.92 
7.38 
7.20 
6.56 
The stability constant increases gradually from Mn through 
Copper which follows Irving -William's order:-
Mn < Fe<Co < Ni < Cu 
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A plot of logK of the Cystine-complexes vs e /r of metal ions 
(Table 21) shows a straight line (Fig.26) indicating that the metal-
ligand interaction is predominantly electrostatic in nature and 
results in the formation of ionic complexes although the possibility 
of some covalent interaction cannot be excluded. 
Table 21 
Log K of DL-cystine and eVr value of divalent metal ions 
Mn"2 
Fe^^ 
Co^^ 
Ni"' 
Cu^^  
LogK 
8.78 
8.95 
9.25 
9.36 
9.47 
eVr 
4.12 
4.35 
4.52 
4.82 
4.60 
9.6 
9.5 
9.4 
9.3 
? 9.1 
9 
8.9 
8.8 
8.7 — , J — 
4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 
e»/r 
Fig. 26 A plot of e /^r vs log K of DL-cystine 
The free energy (AG) decreases gradually from manganese to 
copper with increasing stability constant of complexes. It suggests 
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that the reactions are spontaneous i.e. irreversible. As free energy is 
inversely proportional to the temperature, the stability constant 
decreases with increasing temperature of the system. 
The enthalpy of reaction is negative and decrease from Mn to 
copper with increasing stability constant (Log K).It suggests that 
the reactions are exothermic. Enthalpy changes (AH) accompanying 
the complexation of metal ions in solution is characteristic property 
of reaction 
There will be an increase in the entropy (AS) of the system 
during experiment. Since entropy is a measure of the extent of 
disordemess of the system, more positive value of entropy was 
observed in all the system studied. 
Table-22 
Thermodynamic parameters for DL-cystine 
Metal 
Mn 
Fe 
Co 
Ni 
Cu 
LogK 
8.75 
8.88 
9.24 
9.34 
9.43 
-AG 
(KCal) 
11.93 
12.24 
12.60 
12.71 
12.86 
-AH 
(Cal) 
40.04 
40.45 
42.28 
42.65 
43.15 
AS 
(Cal/degree/mole) 
39.91 
40.26 
42.14 
42.50 
43.00 
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Stability of sulfamethazine, pyriodoxal 5-phosphate and 
DL-cystine upon complextion with divalent metal ions decreases with 
an increase in pH value. 
The values of Gibbs free energy change is negative which 
indicates that the reaction is spontaneous.The enthalpy change is 
also negative which suggests that the reactions are exothermic[56-
58]. As entropy is positive so it also favours the complexation 
reactions. 
59 
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